In this study, we report the first isolation of three antibiotic indole alkaloid compounds from a Pseudomonad bacterium,
Pseudomonas aeruginosa UWI-1. The bacterium was batch fermented in a modified Luria Broth medium and compounds were solvent extracted and isolated by bioassay-guided fractionation. The
[...] Read more.
In this study, we report the first isolation of three antibiotic indole alkaloid compounds from a Pseudomonad bacterium,
Pseudomonas aeruginosa UWI-1. The bacterium was batch fermented in a modified Luria Broth medium and compounds were solvent extracted and isolated by bioassay-guided fractionation. The three compounds were identified as (
1) tris(1H-indol-3-yl) methylium, (
2) bis(indol-3-yl) phenylmethane, and (
3) indolo (2, 1b) quinazoline-6, 12 dione. A combination of 1D and 2D NMR, high-resolution mass spectrometry data and comparison from related data from the literature was used to determine the chemical structures of the compounds. Compounds
1–3 were evaluated in vitro for their antimicrobial activities against a wide range of microorganisms using the broth microdilution technique. Compounds
1 and
2 displayed antibacterial activity against only Gram-positive pathogens, although
1 had significantly lower minimum inhibitory concentration (MIC) values than
2. Compound
3 displayed potent broad-spectrum antimicrobial activity against a range of Gram positive and negative bacteria. Several genes identified from the genome of
P. aeruginosa UWI-1 were postulated to contribute to the biosynthesis of these compounds and we attempted to outline a possible route for bacterial synthesis. This study demonstrated the extended metabolic capability of
Pseudomonas aeruginosa in synthesizing new chemotypes of bioactive compounds.
Full article
